Literature DB >> 12147532

Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins.

Marie-Paule Jacob1, Michèle Cazaubon, Anthony Scemama, Dominique Prié, Françoise Blanchet, Marie-Claude Guillin, Jean-Baptiste Michel.   

Abstract

BACKGROUND: Possible intermediate circulating markers linking blood stasis to vein remodeling were explored in patients with varicose veins in the lower limbs. METHODS AND
RESULTS: Blood was sampled at rest (supine position) and after a stasis of 30 minutes both in the varicose vein (limbs hanging down) and in the brachial vein (arm hanging down) as a paired control. Several endothelial and leukocyte markers were measured in plasma with the use of ELISA kits. Angiotensin-converting enzyme activity was determined by use of a specific substrate. Matrix metalloproteinases (MMPs) 9 and 2 were evaluated with the use of gelatin zymography. No markers were significantly modified after 30 minutes of blood stasis in the brachial vein. After 30 minutes of blood stasis in the varicose vein, oxygen partial pressure decreased (P<0.01). Although thrombomodulin, von Willebrand factor, vascular endothelial growth factor, and MMP-2 were not modified in these conditions, the proteins released by proteolysis from the endothelial membrane intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and angiotensin-converting enzyme were increased (P<0.01). After blood stasis in varicose veins, the leukocyte markers lactoferrin, myeloperoxidase, and interleukin-8 were not modified, whereas L-selectin shed from leukocytes increased (P<0.05), and a major increase in pro-MMP-9, which is released from tertiary granules during polymorphonuclear activation, was observed (P=0.0001).
CONCLUSIONS: The marked increase in plasma pro-MMP-9 activity provides evidence of polymorphonuclear activation and granule release in the varicose vein in response to postural blood stasis. Similarly, detection in the plasma of membrane proteins shed from the endothelium or leukocytes provides evidence of pericellular proteolysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147532     DOI: 10.1161/01.cir.0000027521.83518.4c

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

3.  Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Authors:  Cláudia Torres; Rui Machado; Margarida Lima
Journal:  Heart Vessels       Date:  2019-06-21       Impact factor: 2.037

Review 4.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 5.  Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.

Authors:  Yunfei Chen; Wei Peng; Joseph D Raffetto; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-21       Impact factor: 3.622

Review 6.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.

Authors:  Jeng-Jiann Chiu; Shu Chien
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

7.  Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins.

Authors:  Joseph D Raffetto; Xiaoying Qiao; Vera V Koledova; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2008-05-23       Impact factor: 4.268

Review 8.  Immunological aspects of chronic venous disease pathogenesis.

Authors:  Ewa Grudzińska; Zenon Paweł Czuba
Journal:  Cent Eur J Immunol       Date:  2014-12-15       Impact factor: 2.085

9.  Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors.

Authors:  Johannes Eschrich; Ralph Meyer; Hanna Kuk; Andreas H Wagner; Thomas Noppeney; Sebastian Debus; Markus Hecker; Thomas Korff
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

10.  Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Vessel Plus       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.